| Literature DB >> 30002758 |
Piotr Kulig1, Krzysztof Lewandowski1, Bartłomiej Banaś1, Piotr Piekorz1, Andrzej Kostka1, Maciej Zaniewski1.
Abstract
INTRODUCTION: Endovascular aneurysm repair as a minimally invasive alternative has become a commonly used surgical method for treating patients with abdominal aortic aneurysm (AAA). AIM: To analyze short-term outcomes of endovascular treatment of AAA patients, including ruptured cases.Entities:
Keywords: abdominal aortic aneurysm; endovascular aneurysm repair; short-term outcomes
Year: 2018 PMID: 30002758 PMCID: PMC6041580 DOI: 10.5114/wiitm.2018.73358
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Demographic and clinical-pathological characteristics of the studied group of patients
| Parameter | Unruptured abdominal aortic aneurysm | Ruptured abdominal aortic aneurysm |
|
|---|---|---|---|
| Number of patients | 236 | 11 | |
| Age [years] median (IQR) | 75 (69–80) | 71 (65.5–76.5) | 0.196 |
| Male/female, | 204 (86.4)/32 (13.6) | 10 (90.9)/1 (9.1) | 0.690 |
| Comorbidities, | |||
| General arteriosclerosis | 84 (35.6) | 6 (54.5) | 0.035 |
| Blood hypertension | 127 (53.8) | 5 (45.4) | 0.587 |
| Ischemic heart disease | 122 (51.6) | 5 (45.4) | 0.686 |
| Heart valve disorders | 17 (7.2) | 2 (18.2) | 0.182 |
| Arrhythmia | 37 (15.6) | 1 (9.1) | 0.554 |
| Diabetes mellitus | 47 (19.9) | 4 (36.3) | 0.188 |
| Chronic renal failure | 21 (8.9) | 2 (18.2) | 0.300 |
| Lung disease | 34 (14.4) | 3 (27.3) | 0.243 |
| Thyroid disease | 19 (8.0) | 1 (9.1) | 0.239 |
| Oncological disease | 17 (7.2) | 0 (0) | 0.345 |
| Nicotine addiction, | 61 (25.8) | 3 (27.3) | 0.916 |
| Ejection fraction (%), median (IQR) | 55 (43–60) | 50 (47–55) | 0.910 |
| P-Possum mortality (%), median (IQR) | 15 (9.2–22.3) | 28 (23.5–32.6) | 0.044 |
| Hemoglobin [g/dl], median (IQR) | 13.4 (12–14.4) | 10.8 (7.4–14.4) | 0.045 |
| Urea [mmol/l], median (IQR) | 7.7 (6–9.7) | 11.1 (6.5–16.3) | 0.007 |
| Creatinine [mmol/l], median (IQR) | 95 (79–121.7) | 105 (85–131.7) | 0.098 |
Mann-Whitney test
χ2 test.
Characteristics of abdominal aortic aneurysm (AAA) and perioperative features of the implanted stent graft
| Parameter | Unruptured abdominal aortic aneurysm | Ruptured abdominal aortic aneurysm |
|
|---|---|---|---|
| Number of patients | 236 | 11 | |
| AAA diameter [mm], median (IQR) | 59 (54–64.7) | 60 (58.5–76.5) | 0.657 |
| Symptomatic AAA, yes/no, | 45 (19.1)/191 (80.9) | 11 (100)/0 (0) | < 0.001 |
| Additionally, aneurysm of iliac arteries, | |||
| Right common iliac artery | 58 (24.6) | 3 (27.3) | 0.839 |
| Left common iliac artery | 52 (22) | 3 (27.3) | 0.683 |
| Right external iliac artery | 1 (0.4) | 0 (0) | 0.829 |
| Right internal iliac artery | 7 (2.8) | 1 (9.1) | 0.262 |
| Left external iliac artery | 0 (0) | 0 (0) | |
| Left internal iliac artery | 14 (5.9) | 0 (0) | 0.406 |
| Additionally, thoracic aorta aneurysm, | 3 (1.2) | 0 (0) | 0.707 |
| Anesthesia, | |||
| Local | 105 (44.5) | 0 (0) | 0.004 |
| Subarachnoid | 86 (36.4) | 0 (0) | 0.013 |
| General | 45 (19.1) | 11 (100) | < 0.001 |
| Operation time [min], median (IQR) | 105 (88.7–125.0) | 110 (105–130) | 0.937 |
| Type of implanted stent graft, | |||
| Zenith COOK | 69 (29.3) | 1 (9.1) | 0.147 |
| Endurant Medtronic | 78 (33.1) | 9 (81.8) | 0.001 |
| Excluder Gore | 36 (15.2) | 0 (0) | 0.161 |
| Jotec E-tegra | 47 (19.9) | 1 (9.1) | 0.375 |
| Other | 6 (2.5) | 0 (0) | 0.592 |
| Covering of external iliac arteries, yes/no, | 87 (36.9)/149 (63.1) | 4 (36.4)/7 (63.6) | 0.973 |
| Volume of administered Optiray contrasting agent [ml], median (IQR) | 110 (97.5–132.5) | 130 (110–150) | 0.688 |
| Hospitalization [days], median (IQR) | 6 (4–8) | 7 (5–9) | 0.090 |
Mann-Whitney test
χ2 test.
Short-term observation after endovascular treatment of the studied group of patients
| Short-term observation (up to 30 days after operation) | Unruptured abdominal aortic aneurysm | Ruptured abdominal aortic aneurysm |
|
|---|---|---|---|
| Number of patients | 236 | 11 | |
| Mortality, | 6 (2.5) | 4 (36.4) | < 0.001 |
| Surgical complications, | 18 (7.6) | 5 (45.4) | < 0.001 |
| Type I leak | 3 (1.3) | 1 (9.1) | 0.045 |
| Type II leak | 3 (1.3) | 1 (9.1) | 0.045 |
| Type III leak | 0 (0) | 1 (9.1) | < 0.001 |
| Thrombosis and stent graft blockage with acute ischemia of a lower limb | 6 (2.5) | 0 (0) | 0.592 |
| Bleeding from wound in the groin | 2 (0.8) | 0 (0) | 0.759 |
| Infection of wound in the groin | 4 (1.7) | 1 (9.1) | 0.089 |
| Intestinal necrosis | 0 (0) | 1 (9.1) | < 0.001 |
| Systemic complications, | 19 (8.0) | 8 (72.7) | < 0.001 |
| Arrhythmia | 4 (1.7) | 2 (18.2) | < 0.001 |
| Myocardial infarction | 3 (1.3) | 1 (9.1) | 0.045 |
| Exacerbation of coronary heart disease | 3 (1.3) | 1 (9.1) | 0.045 |
| Pneumonia | 3 (1.3) | 2 (18.2) | < 0.001 |
| Exacerbation of chronic renal failure | 2 (0.8) | 1 (9.1) | 0.015 |
| | 2 (0.8) | 0 (0) | 0.759 |
| Infection of the urinary tract | 2 (0.8) | 1 (9.1) | 0.015 |
| Re-interventions, | 10 (4.2) | 3 (27.3) | < 0.001 |
χ2 test.